Baranick Brian (CIK 1941313) reported 32 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-23). Recent activity: Buy EXAS (33,321 shares), Sell EXAS (137,195 shares), Sell EXAS (795 shares), Sell EXAS (8,151 shares), Sell EXAS (2,009 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 33,321 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 137,195 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 795 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 8,151 | $829,935 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 2,009 | $204,556 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 9,450 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 4,799 | $488,634 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 14,845 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 7,539 | $767,621 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 28,779 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 14,614 | $1.5M |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 16,051 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 3,955 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 42,523 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 21,594 | $2.2M |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 20,584 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 10,453 | $1.1M |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 29,416 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 14,938 | $1.5M |
| 2025-11-06 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 2,858 | $200,289 |
| 2025-08-07 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 5,350 | $0 |
| 2025-08-07 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 2,717 | $127,237 |
| 2025-03-04 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 4,725 | $0 |
| 2025-03-04 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Sell | 2,400 | $114,768 |
| 2025-03-04 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Precision Oncology | Buy | 4,948 | $0 |
Source: SEC Form 4 filings · as of 2026-03-23